Last update :
15/04/2024
Local anesthetic   Lidocaine hydrochloride  
Injection
Mouthwash Ointments
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Jetokaine Turkey
Lidocard Finland
Lidocorit Austria
Lidosen Italy
Lidrian Italy
Linisol Belgium
Locaine Republic of South Africa
Minijet lignocaine Great Britain
Pisacaina Ecuador, Mexico
Plidocain Poland
Rapidocain Switzerland
Remicaine Republic of South Africa
Remicard Republic of South Africa
Xilina Romania
Xylanest Austria
Xylesine Switzerland
Xylestesin Brazil
Xylocain Austria, Canada, Denmark, Finland, Norway, Poland, Sweden, Switzerland
Xylocaina Brazil, Italy
Xylocaine Australia, Belgium, Canada, France, Greece, Luxembourg, Malaysia, Morocco, Netherlands, Slovenia, United States of America
Xylocard Australia, Austria, Belgium, Canada, Egypt, France, Portugal, Saudi Arabia, Sweden
Xylocitin Germany
Xyloneural Austria, Switzerland
Stability in solutions   Injection   Stability in solutions : Lidocaine hydrochloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 0.45 mg/ml 22°C Not specified
21 Day
1126
Level of evidence D

Glass NaCl 0,9% or Glucose 5% 0.45 mg/ml 4°C Protect from light
21 Day
1126
Level of evidence D

Glass NaCl 0,9% or Glucose 5% 2 mg/ml 25°C Light
14 Day
619
Level of evidence D

Glass Ringer’s lactate solution 2 mg/ml 25°C Light
14 Day
619
Level of evidence D

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0.45 mg/ml 22°C Not specified
21 Day
1126
Level of evidence D

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0.45 mg/ml 4°C Protect from light
21 Day
1126
Level of evidence D

Polyvinyl chloride NaCl 0,9% or Glucose 5% 2 mg/ml 25°C Light
14 Day
619
Level of evidence D

Polyvinyl chloride Glucose 5% 4 mg/ml 30°C Not specified
120 Day
1202
Level of evidence B

Polyvinyl chloride Glucose 5% 4 mg/ml 4°C Protect from light
120 Day
1202
Level of evidence B

Polyvinyl chloride Ringer’s lactate solution 2 mg/ml 25°C Light
14 Day
619
Level of evidence D

Polypropylen Syringe None 20 mg/ml 25°C Light
90 Day
1715
Level of evidence B

Polypropylen Syringe None 20 mg/ml 25°C Light
90 Day
1715
Level of evidence B

Polypropylen Syringe None 20 mg/ml 4°C Protect from light
90 Day
1715
Level of evidence B


  Mentions Légales